Health Diagnostic Laboratory

Health Facts

Leading causes of death like heart disease, stroke, and diabetes are largely avoidable through early detection and reversable through proper treatment.¹

50% of heart attack patients
HAVE NORMAL LDL-C¹

76% with Optimal Traditional Lipid Panels

The HDL, Inc. advanced panel reveals
HIGH-RISK MARKERS
in 76% of patients with
optimal traditional lipids²

SUDDEN
DEATH
is the first sign of
cardiovascular
disease in up to⁴

HDL, Inc. patients who consulted
their Clinical Health Consultant showed
TWICE the rate of improvement
with certain health markers than
those who did not⁵

1 in 3 American adults are
DIABETIC OR
PREDIABETIC⁶

Lifestyle intervention
has been shown
to reduce the
development of
TYPE 2
DIABETES^7,8
by 71% over a
3 year period

10-24% of the world's
population has
nonalcoholic fatty
LIVER
DISEASE⁹

NAFLD can often be
reversed with blood
pressure regulation and
AS LITTLE AS A^10,11

Metabolic Syndrome confers a twofold
increase in cardiovascular events and a
1.5X RISK OF DEATH¹²

Clinical Health Consultant involvement
HAS BEEN PROVEN TO
reduce the incidence of Metabolic Syndrome^13,14

Cost Facts

These chronic diseases are also the leading drivers of costs, with heart disease alone exceeding $95.6 billion each year. ² When it comes to costs, prevention is better than cure!

Yearly heart disease
healthcare expenditure
per individual¹⁵

If total healthcare spending in the US
could be reduced by just 1% per year,
the system would save over a
TRILLION DOLLARS
BY 2030¹⁶

Americans with diagnosed diabetes have annual medical expenditures that are $7,900
or approximately 2.3 times higher than they would be in the absence of diabetes.¹³

Even a 1% reduction in BMI could prevent 2.4
million cases of Type II diabetes in the U.S.
SAVING BILLIONS¹⁴

Yearly fatty liver disease
healthcare expenditure
per individual²⁰

Patients without NAFLD show 26%
lower health costs over 5 years²¹

Yearly metabolic syndrome
healthcare expenditure
per individual²²

Patients without metabolic syndrome have
20% lower health costs over 5 years²³

FOOTNOTES

1.Khot UN et al (2003) JAMA. 290(7):898-904.

2.Sachdeva A et al (2009) Am Heart J. 157(1):111-117.

3.Mallory T. Uncovering the hidden risk is no longer a mystery. The Lab Report. 2012;2(2):1-2.

4.Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113(6):e85-151.

5.Warnick R. The impact of health coaching in the prevention of chronic disease. The Lab Report. 2012;2(3):1-3.

6.Centers for Disease Control and Prevention. National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.7. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.

7.Centers for Disease Control. National Diabetes fact Sheet. 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf Accessed July 20th 2012.

8.Alba LM, Lindor K. Review article: Non-alcoholic fatty liver disease. Aliment pharmacol Ther 2003;17(8):977-86.

9.Caporaso N, Morisco F, Camera S, Graziani G, et al. Dietary approach in the prevention and treatment of NAFLD. Front Biosci 2012;17:2259-2278.

10.Davis GL, Roberts WL. The healthcare burden imposed by liver disease in aging baby boomers. Curr Gastroenterol Rep 2010;12:1-6.

11.Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol 2010;56(14):1113-32.

12.Appel LJ et al. Comparative effectiveness of weight-loss interventions in clinical practice. New Engl J Med 2011;365(21):1959-1968.

13.American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–1046

14.Wang G, Pratt M, Macera CA, Zheng ZJ, Heath G. Physical activity, cardiovascular disease, and medical expenditures in U.S. adults. Ann Behav Med 2004;28:88-94.

15.extrapolated from projections by the Center for Medicare and Medicaid Services (CMS) and the Congressional Budget Office (CBO).

16.Diabetes Prevention Research Group. The 10 year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention. Diabetes Care 2012;35:723-730.

17.16 – Wang YC et al. Lancet 2011;378:815-825.

18.American Diabetes Association. “Economic Costs of Diabetes in the U.S. in 2007”. Diabetes Care. Vol. 31, No. 3, pp. 1-20.

19.Rakoski MO, McCammon RJ, Plette JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology 2012;55:184-191.

20.Baumeister SE, et al. Impact of fatty liver disease on health care utilization and costs in a general population.: A 5 year observation. Gastroenterology 2008;134:85.

21.Boudreau DM, Malone DC, Raebel MA, Fishman PA, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord 2009;7(4):305-14.

22.Curtis LH, Hammill BG, Bethel MA, Anstrom KJ, Gottdiener JS, Schulman KA. Costs of the metabolic syndrome in the elderly: Findings from the Cardiovascular Health Study. Diabetes Care 2007;30:2553–2558.